Literature DB >> 23918613

Variability of total lesion glycolysis by 18F-FDG-positive tissue thresholding in lung cancer.

Eric Laffon1, Henri de Clermont, Frederic Lamare, Roger Marthan.   

Abstract

UNLABELLED: The aim of this work was to assess the variability of total lesion glycolysis (TLG) measurements in lung cancer patients, obtained with fixed percentages of the maximum standardized uptake value (SUVmax) thresholds.
METHODS: Thirteen lesions (10 patients) were analyzed in 10 successive 2.5-min frames of an (18)F-FDG PET dynamic acquisition obtained between 60 and 110 min after injection. (18)F-FDG-positive lesion volume, associated average SUV (SUVmean), and TLG (volume × SUVmean) were assessed in each frame using thresholds of 40%, 50%, 60%, 70%, and 80%. For each threshold, the average relative SD of TLG, leading to relative measurement error and repeatability, was calculated over the lesion series. The dependence of TLG variability on volume and SUVmean variability was also assessed.
RESULTS: The average relative SD of TLG correlated strongly with threshold: 1.0866 × exp(0.0472 × threshold) (r = 0.999; P < 0.01). For the 40% threshold, average TLG over the series was 225.9 g (range, 41.7-1,086.3), relative measurement error and repeatability were 14.5%-20.4% (95% confidence interval), and no significant difference was found between TLG and volume variability. For the other thresholds, TLG variability was significantly lower or greater than volume or SUVmean variability, respectively.
CONCLUSION: In current clinical practice, a formula allows quick estimation of TLG variability for any percentage of the SUVmax threshold: the higher the threshold the greater the TLG variability.

Entities:  

Keywords:  18F-FDG PET; functional parameter; lung cancer; repeatability; total lesion glycolysis

Mesh:

Substances:

Year:  2013        PMID: 23918613     DOI: 10.2967/jnmt.113.122952

Source DB:  PubMed          Journal:  J Nucl Med Technol        ISSN: 0091-4916


  6 in total

1.  Variability of average SUV from several hottest voxels is lower than that of SUVmax and SUVpeak.

Authors:  E Laffon; F Lamare; H de Clermont; I A Burger; R Marthan
Journal:  Eur Radiol       Date:  2014-06-04       Impact factor: 5.315

Review 2.  Current Methods to Define Metabolic Tumor Volume in Positron Emission Tomography: Which One is Better?

Authors:  Hyung-Jun Im; Tyler Bradshaw; Meiyappan Solaiyappan; Steve Y Cho
Journal:  Nucl Med Mol Imaging       Date:  2017-09-19

3.  18F-FDG PET/CT in diagnostic and prognostic evaluation of patients with cardiac masses: a retrospective study.

Authors:  Chunxia Qin; Fuqiang Shao; Fan Hu; Wenyu Song; Yangmeihui Song; Jinxia Guo; Xiaoli Lan
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-12-05       Impact factor: 9.236

4.  Quantification of Metastatic Prostate Cancer Whole-Body Tumor Burden with 18F-FDG PET Parameters and Associations with Overall Survival After First-Line Abiraterone or Enzalutamide: A Single-Center Retrospective Cohort Study.

Authors:  Andreas G Wibmer; Michael J Morris; Mithat Gonen; Junting Zheng; Hedvig Hricak; Steven Larson; Howard I Scher; Hebert Alberto Vargas
Journal:  J Nucl Med       Date:  2021-01-08       Impact factor: 10.057

5.  The assessment of correlation and prognosis among 18F-FDG uptake parameters, Glut1, pStat1 and pStat3 in surgically resected non-small cell lung cancer patients.

Authors:  Hayato Kaida; Koichi Azuma; Akihiko Kawahara; Eiji Sadashima; Satoshi Hattori; Shinzo Takamori; Jun Akiba; Kiminori Fujimoto; Axel Rominger; Takamichi Murakami; Kazunari Ishii; Masatoshi Ishibashi
Journal:  Oncotarget       Date:  2018-08-10

6.  One Versus Up-to-5 Lesion Measurements for Response Assessment by PERCIST in Patients with Lung Cancer.

Authors:  Soo Jin Kwon; Joo Hyun O; Ie Ryung Yoo
Journal:  Nucl Med Mol Imaging       Date:  2021-04-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.